Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors”

Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors”

NTRK-fusion positive tumors are a rare finding, but targeted therapy demonstrates persistent and sustained systemic and intracranial responses to entrectinib. This resolution proposes algorithms for diagnosing NTRK translocations in various solid tumors and discuses clinical data on the efficacy and...

Full description

Bibliographic Details
Main Authors: Valeriy V. Breder, Liudmila G. Zhukova, Larisa V. Bolotina, Irina A. Demidova, Yaroslav A. Zhulikov, Elena V. Lubennikova, David R. Naskhletashvili, Sergey V. Orlov, Rashida V. Orlova, Ilya S. Romanov, Nikita A. Savelov, Ksenia A. Sarantseva, Alexandra S. Tyulyandina, Mikhail Yu. Fedyanin
Format: Article
Language:Russian
Published: IP Habib O.N. 2023-12-01
Series:Современная онкология
Subjects:
ntrk gene fusions
entrectinib
trk inhibitors
molecular testing in solid tumors
secretory carcinoma
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/159394/pdf

Internet

https://modernonco.orscience.ru/1815-1434/article/viewFile/159394/pdf

Similar Items